Article

Long-standing COVID-19 disease in immunedeficient patients; case reports and literature review

2022-11-14

Abstract excerpt

<h4>Introduction: </h4> Patients with primary or secondary immunodeficiency are at higher risk of severe disease and death following SARS-CoV-2 infection compared with the general population. We describe here the effect of rituximab therapy in 5 patients with humoral and cellular immune deficiencies (1 patient with thymoma or Good`syndrome, 1 HIV/AIDS positive patient, 2 patients with Multiple Sclerosis (MS) and 1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa7ee9b8-44e2-5c48-8676-565f9bbf2514
DOI: 10.21203/rs.3.rs-2225095/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Long-standing COVID-19 disease in immunedeficient patients; case reports and literature reviewDOI 10.21203/rs.3.rs-2225095/v1Read

Prolonged COVID-19 Infection in a Patient with Multiple Sclerosis and Rituximab-TreatmentSemantic proximity Read

Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccinesSemantic proximity Read

Atypical COVID-19 dynamics in a patient with Mantle Cell Lymphoma Exposed to RituximabSemantic proximity Read

Preserved T-cell Response in anti-CD20 Treated Multiple Sclerosis Patients Following SARS-CoV-2 VaccinationSemantic proximity Read

Distinct Patterns of Humoral and Cellular Immune Responses Following SARS-CoV-2 mRNA Vaccination in Patients With Immune-Mediated Neurological Disorders on Anti-CD20 Therapy: A Prospective Cohort StudySemantic proximity Read

High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4+ T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19.Semantic proximity Read

Response to: ‘Correspondence on ‘SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response’’ by Westhoff et alSemantic proximity Read

Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?Semantic proximity Read

Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cellsSemantic proximity Read

Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndromeSemantic proximity Read

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraSemantic proximity Read

Profile of SARS-CoV-2-specific CD4 T cell response: Relationship with disease severity and impact of HIV-1 and active<i>Mycobacterium tuberculosis</i>co-infectionSemantic proximity Read